Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CALCRLCHRM1CHRM2CHRM3F2RMAOAMAOBMAP2K1MAP2K2NTRK1NTRK2NTRK3OPRD1OPRK1OPRM1P2RY12PKLRSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASLC18A2SLC6A2SLC6A3TLR7TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8dacAdacBdacCfolAftsImrcAmrcBmrdApolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmB1rpmB2rpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmHrpmIrpmJrpmJ2rpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsR1rpsR2rpsSrpsTrpsUrpsZykgMykgO
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA known ✓ | P21397 | 1/20 | 0.39 |
| ▸ | MAOB known ✓ | P27338 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 4/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | CA5A | P35218 | 3/20 | 0.40 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 5/20 | 0.39 |
| ▸ | LMNA | P02545 | 4/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | CA9 | Q16790 | 3/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | THPO | P40225 | 1/20 | 0.39 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL27702892 | 1.00 | BLM (0.42) | BLMKDM4ECYP2D6CYP2C19NPSR1 | |
| Sulfuric Acid SCHEMBL31648906 | 1.00 | BLM (0.42) | BLMKDM4ECYP2D6CYP2C19NPSR1 | |
| SCHEMBL27723465 | 0.93 | CA2 (0.39) | BLMKDM4ECYP2D6CYP2C19NPSR1 | |
| SCHEMBL9157890 | 0.86 | LMNA (0.50) | BLMKDM4ECA5ACA2LMNA | |
| SCHEMBL10181 | 0.86 | — | — | |
| SCHEMBL28150226 | 0.83 | CRBN (0.32) | BLMCA5ACA2LMNATSHR | |
| SCHEMBL27486772 | 0.83 | CA2 (0.36) | BLMCA5ACA2LMNATSHR | |
| Hydrochloric Acid SCHEMBL180387 | 0.82 | — | — | |
| SCHEMBL11876964 | 0.82 | — | — | |
| Hydrochloric Acid SCHEMBL6900073 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117756773-A | Preparation process of heliotropin | 宿迁市万和泰化工有限公司 | 2024-03-26 | — | — | CN | claimed |
| CN-117005110-A | Long-acting electret melt-blown cloth and preparation method thereof | 孚韦(内蒙古)安全装备有限公司 | 2023-11-07 | — | — | CN | claimed |
| CN-115925639-A | Antineoplastic fluorouracil and preparation process thereof | 上海旭东海普南通药业有限公司 | 2023-04-07 | — | — | CN | claimed |
| CN-114210238-A | Fluorouracil refining method and device | 上海旭东海普南通药业有限公司 | 2022-03-22 | — | — | CN | claimed |
| CN-113563233-A | Anti-carbonization concrete reinforcing agent and preparation method thereof | 石家庄市长安育才建材有限公司 | 2021-10-29 | — | — | CN | claimed |
| CN-110396116-B | [ N, O ] bidentate nickel and palladium complex of ketone-imidazoline-2-imine ligand, and preparation method and application thereof | 东华大学 | 2020-07-28 | — | — | CN | claimed |
| CN-106117242-B | Tetrahydric thiapyran miazines derivative and the preparation method and application thereof | 山东大学 | 2018-08-03 | — | — | CN | claimed |
| CN-106117242-A | Tetrahydric thiapyran miazines derivative and preparation method and application | 山东大学 | 2016-11-16 | — | — | CN | claimed |
| EP-1042292-A1 | METHOD FOR PRODUCING ISOUREAS | Takeda Chemical Industries, Ltd. (JP) | 2000-10-11 | — | — | EP | claimed |
| WO-1999033809-A1 | METHOD FOR PRODUCING ISOUREAS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1999-07-08 | — | — | WO | claimed |
| JP-4089466-A | — | — | None | — | — | JP | disclosed |
| JP-61180760-A | — | — | None | — | — | JP | disclosed |
| CN-119569613-A | Method for preparing O-methyl-N-nitroisourea | 武汉青江化工黄冈有限公司 | 2025-03-07 | — | — | CN | disclosed |
| US-20250011333-A1 | PYRAZOLO-QUINAZOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS KINASE INHIBITORS | NERVIANO MEDICAL SCIENCES SRL (IT) | 2025-01-09 | — | — | US | disclosed |
| EP-4380494-A1 | COMPOSITION FOR ISOLATING TISSUE | Solventum Intellectual Properties Company (US) | 2024-06-12 | — | — | EP | disclosed |
| US-4617401-A | ANTISPASMODIC AGENTS, VASODILATORS | SUNTORY LTD. (JP) | 1986-10-14 | — | — | US | disclosed |
| JP-S61180760-A | PRODUCTION OF O-METHYLISOUREA ACETIC ACID SALT | DAINIPPON INK & CHEM INC | 1986-08-13 | — | — | JP | disclosed |
| EP-0039903-B1 | 8-SUBSTITUTED PYRROLIZIDINES AND QUATERNARY AMMONIUM SALTS THEREOF | SUNTORY KABUSHIKI KAISHA (JP) | 1986-04-09 | — | — | EP | disclosed |
| US-4564382-A | HERBICIDES | HOECHST AKTIENGESELLSCHAFT (DE) | 1986-01-14 | — | — | US | disclosed |
| EP-0039903-A2 | 8-Substituted pyrrolizidines and quaternary ammonium salts thereof | SUNTORY KABUSHIKI KAISHA (JP) | 1981-11-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250011333-A1 | PYRAZOLO-QUINAZOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS KINASE INHIBITORS | MAP3K5, MAP3K9, MAP4K2 | MAOA 2206/4885MAOB 1561/4885BLM 2225/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.